ClinicalTrials.gov
public full text
Public Domain
Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)
This treatment protocol is designed to provide convalescent plasma as a therapeutic option for patients diagnosed with and hospitalized for COVID-19 with symptoms ranging from mild to life-threatening.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effectiveness of ACB-IP 1.0 Convalescent Plasma in COVID-19 Infection#871069
- Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions#903862
- An Observational Study of Patients With Coronavirus Disease 2019#829937
- Long-term Follow-up Study of COVID-19#826991
- EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19#1045339
Record · ID 1212879
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive